Wealthfront Inc. bought a new stake in shares of Envision Healthcare (NYSE:EVHC) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 12,385 shares of the company’s stock, valued at approximately $476,000.
Several other hedge funds also recently made changes to their positions in EVHC. CIBC World Markets Inc. acquired a new stake in shares of Envision Healthcare during the 4th quarter worth approximately $208,000. OLD Mutual Customised Solutions Proprietary Ltd. grew its position in shares of Envision Healthcare by 88.2% during the 4th quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 6,401 shares of the company’s stock worth $221,000 after buying an additional 3,000 shares during the period. CENTRAL TRUST Co grew its position in shares of Envision Healthcare by 79.7% during the 4th quarter. CENTRAL TRUST Co now owns 6,626 shares of the company’s stock worth $229,000 after buying an additional 2,939 shares during the period. Zeke Capital Advisors LLC acquired a new stake in shares of Envision Healthcare during the 1st quarter worth approximately $229,000. Finally, Alps Advisors Inc. acquired a new stake in shares of Envision Healthcare during the 4th quarter worth approximately $235,000.
Envision Healthcare opened at $41.74 on Tuesday, according to Marketbeat Ratings. Envision Healthcare has a 12-month low of $41.52 and a 12-month high of $42.64. The company has a debt-to-equity ratio of 0.65, a current ratio of 2.27 and a quick ratio of 2.25. The firm has a market capitalization of $5.13 billion, a P/E ratio of 15.91, a price-to-earnings-growth ratio of 0.96 and a beta of 0.43.
Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings data on Monday, May 7th. The company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.64 by $0.07. Envision Healthcare had a return on equity of 4.59% and a net margin of 1.41%. The business had revenue of $2.08 billion for the quarter, compared to analysts’ expectations of $2.02 billion. During the same period last year, the business earned $0.77 EPS. The business’s revenue was up 10.6% on a year-over-year basis. sell-side analysts expect that Envision Healthcare will post 3.39 earnings per share for the current year.
EVHC has been the subject of several recent analyst reports. Jefferies Group set a $46.00 price objective on shares of Envision Healthcare and gave the stock a “buy” rating in a research report on Thursday, March 15th. Royal Bank of Canada reissued a “buy” rating and issued a $48.00 price target on shares of Envision Healthcare in a research report on Thursday, March 1st. SunTrust Banks lifted their price target on shares of Envision Healthcare to $45.00 and gave the company a “buy” rating in a research report on Thursday, March 1st. Canaccord Genuity reissued a “buy” rating and issued a $46.00 price target (up previously from $32.00) on shares of Envision Healthcare in a research report on Wednesday, February 28th. Finally, Robert W. Baird set a $45.00 price target on shares of Envision Healthcare and gave the company a “buy” rating in a research report on Monday, February 26th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $41.10.
About Envision Healthcare
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare (NYSE:EVHC).
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.